Literature DB >> 8617329

Leishmania amazonensis: the Asian rhesus macaques (Macaca mulatta) as an experimental model for study of cutaneous leishmaniasis.

V F Amaral1, V A Ransatto, F Conceicão-Silva, E Molinaro, V Ferreira, S G Coutinho, D McMahon-Pratt, G Grimaldi.   

Abstract

As a means of assessing the usefulness of the Rhesus macaque (Macaca mulatta) as a nonhuman primate model for studying cutaneous leishmaniasis, monkeys were infected with Leishmania amazonensis. Variation in the level of susceptibility was found; however, animals inoculated with 10(8) promastigotes provided consistent results as indicated by an earlier onset and/or larger size of lesions. Three monkeys, which had recovered from skin lesions, were challenge-infected using the same parasite strain/dose; although these animals remained susceptible to homologous infection, lesion size was smaller and healed faster than in the initial infection. The immunologic features during infection were assessed. Levels of IgM and IgG antibodies to promastigote antigens rose during active infection and then declined; immunoblot analyses indicated that numerous leishmanial antigens (predominately >30 kDa) were recognized. Delayed type hypersensitivity (DTH) responses and proliferative responses (PBL) developed during active infection and/or rechallenge. Circulating peripheral T cell subpopulations varied throughout the course of infection. Initially (6-8 weeks p.i.), CD4+ T cells appear to predominate; subsequently (15-21 weeks p.i.), an increase in CD8+ T cells was observed. Pathologic analyses indicated that lesions contained amastigotes with a mononuclear infiltrate of macrophages, lymphocytes, and plasma cells, and formation of tuberculoid-type granulomas. As the progression and resolution of leishmanial infection in rhesus macaques are very similar to those observed in humans, this primate model could be employed for elucidating the mechanisms of protective immunity in cutaneous leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617329     DOI: 10.1006/expr.1996.0005

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  7 in total

1.  Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs.

Authors:  Barbara Flynn; Vivian Wang; David L Sacks; Robert A Seder; Daniela Verthelyi
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease.

Authors:  A Campos-Neto; R Porrozzi; K Greeson; R N Coler; J R Webb; Y A Seiky; S G Reed; G Grimaldi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primates.

Authors:  Montserrat Puig; Andrzej Grajkowski; Malgorzata Boczkowska; Cristina Ausín; Serge L Beaucage; Daniela Verthelyi
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

4.  Clinical and microbiological parameters of naturally occurring periodontitis in the non-human primate Macaca mulatta.

Authors:  A P V Colombo; B J Paster; G Grimaldi; T G B Lourenço; A Teva; A Campos-Neto; J McCluskey; H Kleanthous; T E Van Dyke; P Stashenko
Journal:  J Oral Microbiol       Date:  2017-11-25       Impact factor: 5.474

5.  Non-human primates and Leishmania immunity.

Authors:  Sonia André; Vasco Rodrigues; Morgane Picard; Ricardo Silvestre; Jérôme Estaquier
Journal:  Cytokine X       Date:  2020-10-12

Review 6.  A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis.

Authors:  Emily Rose Mears; Farrokh Modabber; Robert Don; George E Johnson
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03

7.  Clinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigen.

Authors:  Gabriel Grimaldi; Antonio Teva; Renato Porrozzi; Marcelo A Pinto; Renato S Marchevsky; Maria Gabrielle L Rocha; Miriam S Dutra; Oscar Bruña-Romero; Ana-Paula Fernandes; Ricardo T Gazzinelli
Journal:  PLoS Negl Trop Dis       Date:  2014-06-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.